RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–In response to the growing and ever-changing clinical research landscape and the need to bring innovative treatments to patients faster, Worldwide Clinical Trials (Worldwide), a leading global, full-service contract research organization (CRO), has expanded its Site Alliance Collaboration with new partners across the United States and Europe. Additions include new relationships with NEXT Oncology in Spain and the pan-European Pratia Research Platform, along with its oncology research units – supported by a dedicated Global Site Alliances role, established at Worldwide last year.
“Pratia is excited to collaborate more strategically with Worldwide Clinical Trials to reduce the time to market for sponsors and, more importantly, for patients,” said Jack Evans, Executive Director, Portfolio Management, Pratia SA. “Through earlier engagement, closer collaboration, and alignment, we can collectively improve patient access to clinical trials and, critically, access to new therapies.”